Malaria caused by Plasmodium vivax

Plasmodium vivax is a malaria parasite species detected through testing, often alongside symptoms such as fever, chills or muscle aches. The blood-stage infection can cause illness, while dormant forms in the liver may later reactivate. A clinician therefore considers both immediate treatment and a plan to prevent recurrence.

The right medicines depend on pregnancy status, age, an enzyme condition that affects medicine safety, other illnesses, medicines and the place where infection was acquired. Do not assume a medicine used for another malaria species is suitable for vivax.

Arrange prompt review after a positive result and provide the full laboratory report and travel history. Take the prescribed treatment for the full instructed course. Ask specifically whether testing for an enzyme deficiency is needed before a medicine aimed at liver-stage parasites can be used.

Keep a record of doses and symptoms, take fluids in small frequent amounts if tolerated, and contact the treating team if vomiting prevents you from keeping medicine down. Follow-up is useful even when fever settles, because a later recurrence can need reassessment.

Seek emergency care for confusion, fainting, seizures, breathing difficulty, severe weakness, repeated vomiting, inability to drink, yellowing of the eyes or very little urine. A return of fever or chills after treatment also warrants medical review.

Pregnancy, childhood and serious long-term illness lower the threshold for urgent assessment. Tell the care team that vivax malaria was diagnosed and mention all medicines you have taken.

Ask whether the test confirms vivax, whether liver-stage treatment is needed, whether enzyme testing comes first, how follow-up will be arranged, and which symptoms should trigger immediate review. Clarify what to do after a missed or vomited dose.